Safety and efficacy of trifluridine/tipiracil +/− bevacizumab plus XB2001 (anti-IL-1α antibody): a single-center phase 1 trial

Abstract In the tumour microenvironment, IL-1α promotes neoangiogenesis, matrix remodelling, tumour proliferation, chemoresistance, and metastases. Highly expressed in human colorectal cancers, IL-1α is associated with poor prognosis. XB2001, a fully human monoclonal antibody neutralizing IL-1α, was...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Marion Thibaudin, Nicolas Roussot, Chloé Burlot, Antonin Schmitt, Julie Vincent, Zoé Tharin, Leila Bengrine, Hélène Bellio, Aurélie Bertaut, Léa Hampe, Susy Daumoine, Emilie Rederstorff, Morgane Peroz, Titouan Huppe, Valentin Derangère, David Rageot, John Simard, Caroline Truntzer, Jean David Fumet, Francois Ghiringhelli
Format:	Artigo
Sprog:	Inglês
Udgivet:	Nature Publishing Group 2025-01-01
Serier:	Signal Transduction and Targeted Therapy
Online adgang:	https://doi.org/10.1038/s41392-024-02116-4
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!